If MSB is to be removed from S&P ASX 200...., page-37

First 37 Last

Share
Profile

Follow
Rappa

6,264 Posts.

20/07/16

00:42

Post #: 18312253
Share

Originally posted by wombat53 ↑

"It was a risky Kamikaze move, but it paid great dividends.

Once I got my break-even point to $1.25, I sold all The MSB shares purchased earlier at over $1.50 to cover some capital gains that were due."
How could you have possibly have broken even when the price has hardly ever been below 1.25 (not since 2009, and I'm sure your weren't a holder then)? You could only have bought higher than that price and compounded losses with each successive buy...correct me if I'm wrong.
So, you made or lost money when averaging down on MSB? It sounds like you went out of your way to incur a Cap Loss to offset against Cap Gains elsewhere. Nothing wrong with this...tax loss selling (plenty wrong with averaging down)...but pls don't pretend you made money, or even broke even... by averaging down. The numbers don't jive.
Am I missing something?
P.S It seems you salvaged what what was left, and bot another stock (CUV), which has risen for you.
Which is exactly what I was saying in the Post to which you responded.
And why are you ashamed of making money, even if said in jest? Must be some kind of medieval religious motive here ("filthy lucre" etc...)
BTW, kamikaze went out of style around 1945 or so.... with the exception of the literary trope I employed when I used the term.... the expected kamikaze wave of sellers expected if / when price reaches their entry point, and they can't wait to sell and "break even", after endless years of painful draw down.
Another exception would be artfully and rapidly capturing a stock at a low before a reversal (which is literally impossible with a constantly falling stock).
P.S Were you also long SGH? DSH? All the way to the bottom? To maximize losses to offset against huge Cap Gains elsewhere and minimize tax?
PPS It's better to make money and pay the tax on it, than to not make it all.
Thanks

Expand

I lost money averaging down when UBI collapsed, also ACL and TIS.

The losses were not as great as the potential loss to MSB as I have invested much of my portfolio into MSB. At one point MSB exceeded 50% of my holdings, but now it is down to around 25 %

If CUV keeps going to become the next Sirtex then my MSB will drop to under 20%.
Still a lot, but I'm comfortable with that at the moment.

MSB Price at posting: $1.11 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

IRE

Iress runs 'hot' for Wealth Within's stock tips

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

There are more pages in this discussion • 244 more messages in this thread...

First 37 Last

Add MSB (ASX) to my watchlist

(20min delay)
Last $1.21		Change 0.040(3.42%)		Mkt cap ! $1.381B

Open	High	Low	Value	Volume
$1.17	$1.22	$1.17	$5.683M	4.776M

Buyers (Bids)

No.	Vol.	Price($)
1	20000	$1.21

Sellers (Offers)

Price($)	Vol.	No.
$1.21	19746	3

View Market Depth

No.	Vol.	Price($)
1	20000	1.205
2	55500	1.200
3	60292	1.195
1	33180	1.190
3	67965	1.185

Price($)	Vol.	No.
1.210	19746	3
1.215	45236	7
1.220	190559	15
1.225	70181	4
1.230	169274	5

Last trade - 16.10pm 01/10/2024 (20 minute delay)

MSB (ASX) Chart

If MSB is to be removed from S&P ASX 200...., page-37

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

If MSB is to be removed from S&P ASX 200...., page-37

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Failure to report prompts ASX to impose multiple company suspensions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News